<p>A) Representative images of mice with intraperitoneal implants of HeyA8-CXCR4-CBRN/Ar-CBC and HeyA8-CXCL12-GL cells. Images were obtained before and following 5 days of treatment with osmotic pumps containing AMD3100 or vehicle control. Scale bar depicts ranges of photon flux values displayed on pseudocolor images. B) Fluorescence from ovarian cancer cells was measured in living mice treated with AMD3100 or vehicle control. Graph shows mean values+SEM for fluorescence relative to values measured on day 0 before beginning treatment. Arrows show the period when osmotic pumps were in place. C) Quantified photon flux data for click beetle red complementation in mice treated with AMD3100 or vehicle control, respectively. Data were normalized ...
<p>Representative images are shown. (A) Photograph images of mouse to show location of tumor. (B) Th...
<p>(A–B) Mice in both sham and MI groups received 1 million MSCs by intramyocardial injection (n=5)....
<p>(A) Image of a 96-well plate containing 100 μl of 2-fold serial dilutions of TcCOL-NLuc trypomast...
<p><b>A,</b> Tumor-bearing mice were injected with AMD3465 a single subcutaneous dose of 2.5 mg/kg. ...
Chemokine CXCL12 and receptor CXCR4 have emerged as promising therapeutic targets for ovarian cancer...
<p>Representative images are shown. (A) Photograph images of mouse to show location of tumor. (B) Th...
<p>(A) A photomontage of three representative BALB/c nu/nu mice (out of 14) serially imaged from day...
<p>(A) Bioluminescence imaging of nude mice injected with P4 MSCs cells isolated from the tri-fusion...
<p>A) Representative images of bioluminescence 3–5 weeks after tumour cell injection showing tumour ...
<p>(A) Bioluminescent images of tumor-bearing mice were obtained at 0, 3, 5, 7, 10 and 14 d in the s...
<p>(<b>A</b>) <i>In vivo</i> changes in light production by U87 tumors expressing Pluc, resulting fr...
<p>(<b>A</b>), Quantification of photon intensities on a Xenogen IVIS Lumina XRMS Series III live an...
<p>Mice #1–6 are labeled in both cisplatin and saline treatment groups. Scale bar = 10 mm.</p
<p>MCF7 and BT474 tumors were established on the left and right flank of nude mice, respectively. At...
<p>Representative images are shown. (A) Fluorescent IVIS image with filter pair ICG of before (contr...
<p>Representative images are shown. (A) Photograph images of mouse to show location of tumor. (B) Th...
<p>(A–B) Mice in both sham and MI groups received 1 million MSCs by intramyocardial injection (n=5)....
<p>(A) Image of a 96-well plate containing 100 μl of 2-fold serial dilutions of TcCOL-NLuc trypomast...
<p><b>A,</b> Tumor-bearing mice were injected with AMD3465 a single subcutaneous dose of 2.5 mg/kg. ...
Chemokine CXCL12 and receptor CXCR4 have emerged as promising therapeutic targets for ovarian cancer...
<p>Representative images are shown. (A) Photograph images of mouse to show location of tumor. (B) Th...
<p>(A) A photomontage of three representative BALB/c nu/nu mice (out of 14) serially imaged from day...
<p>(A) Bioluminescence imaging of nude mice injected with P4 MSCs cells isolated from the tri-fusion...
<p>A) Representative images of bioluminescence 3–5 weeks after tumour cell injection showing tumour ...
<p>(A) Bioluminescent images of tumor-bearing mice were obtained at 0, 3, 5, 7, 10 and 14 d in the s...
<p>(<b>A</b>) <i>In vivo</i> changes in light production by U87 tumors expressing Pluc, resulting fr...
<p>(<b>A</b>), Quantification of photon intensities on a Xenogen IVIS Lumina XRMS Series III live an...
<p>Mice #1–6 are labeled in both cisplatin and saline treatment groups. Scale bar = 10 mm.</p
<p>MCF7 and BT474 tumors were established on the left and right flank of nude mice, respectively. At...
<p>Representative images are shown. (A) Fluorescent IVIS image with filter pair ICG of before (contr...
<p>Representative images are shown. (A) Photograph images of mouse to show location of tumor. (B) Th...
<p>(A–B) Mice in both sham and MI groups received 1 million MSCs by intramyocardial injection (n=5)....
<p>(A) Image of a 96-well plate containing 100 μl of 2-fold serial dilutions of TcCOL-NLuc trypomast...